Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2-Reference-Cited by-同舟云学术

Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2

Published:2014-07 Issue:1 Volume:20 Page:85-102
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Gurzov Esteban N.,Tran Melanie,Fernandez-Rojo Manuel A.,Merry Troy L.,Zhang Xinmei,Xu Yang,Fukushima Atsushi,Waters Michael J.,Watt Matthew J.,Andrikopoulos Sofianos,Neel Benjamin G.,Tiganis Tony

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference72 articles.

1. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans;Anderson;J. Clin. Invest.,2009

2. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent;Aoyama;Hepatology,2012

3. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism;Barclay;Endocrinology,2011

4. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis;Biddinger;Cell Metab.,2008

5. Selective versus total insulin resistance: a pathogenic paradox;Brown;Cell Metab.,2008

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy;European Journal of Medicinal Chemistry;2024-11

2. Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases;Acta Pharmaceutica Sinica B;2024-08

3. A crucial role of adenosine deaminase in regulating gluconeogenesis in mice;Journal of Biological Chemistry;2024-07

4. A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches;Diabetes Therapy;2024-02-02

5. Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease;Current Drug Targets;2024-02